Riyadh, Saudi Arabia: International Cold Chain Management Congress (ICCM), co-organised by the Saudi Pharmaceutical Society (SPS) and Maarefah Management will discuss innovation and critical challenges in the pharmaceutical supply chain. A must attend event participated by industry leaders, the ICCM is happening on February 26 - 28 at the Movenpick in Riyadh.

The Kingdom of Saudi Arabia accounts for almost 59 percent of the pharmaceutical purchase in the region and the healthcare sector also holds the third largest share of 15.6 percent (SAR 172 billion) in the budget expenditure set aside by the government for 2019. Moreover, pharmaceutical sector in the country expects to touch around SAR 36 billion in the next five years with a growth of 4.9 percent CAGR per annum. 

The Saudi government is resolved to channel funds into optimising local pharmaceutical industry and to create a robust healthcare infrastructure, which calls for improved cold chain management and perfect last mile delivery. Ensuring the quality and safety of products, packaging, as well as the security and storage of temperature sensitive products remain a big challenge in the kingdom with its arid climate and geography. The Kingdom also has very strict regulatory framework for the transportation and handling of temperature-sensitive pharmaceuticals. These and other important topics will be discussed at the Congress with a focus on upcoming trends and innovative technologies disrupting the sector.

Khalid Alburikan, President of Saudi Pharmaceutical Society (SPS) and corporate director of pharmacy services at King Saud University Medical City will open and chair the Congress, attended by over 150 delegates. The event will provide stakeholders involved in Cold Chain industry with latest trends and highlight key solutions to challenges facing the pharmaceutical cold chain industry through topical panel discussions, featured presentations, specialised workshops, and ‘Meet the Expert’ sessions. Experts from leading solution providers in the pharmaceutical supply chain including Honeywell Middle East, Hino - Jamjoom Vehicles and Equipment, HALA Supply Chain Services Co, and Lisaline will be participating at the Congress.

According to Jamjoom Vehicles and Equipments, “In tandem with the dynamic progress of the Saudi economy, Hino Motors has evolved in the market as a leading solution provider for transporting sophisticated and sensitive merchandise. Jamjoom Vehicles and Equipment (JVE) been a longstanding partner of HINO Motors for the last 5 decades in the country Total Support philosophy of Maximizing uptime and Minimizing downtime goes hand in glove with the requirements of pharmaceutical companies. The robustness & versatility of HINO trucks coupled with customer first approach is the pathway we aim to embark on in the future, and the Cold Chain Congress will be a stepping-stone in our onward journey.”

The three-day Congress will expound on the Kingdom’s burgeoning healthcare industry especially cold chain pharmaceutical products supply chain. ICCM is an ideal platform that brings together players from healthcare, logistics, as well as support solution sector. Shedding light on the topic ‘Managing Drug Shortage from local manufacturing view & effects on Cold Chain Industry’ will be Mr. Faisal Al Tlasi, Deputy Chairman, National Committee for Pharmaceuticals Industries NCPI and Governmental and institution affairs Director GCC, Hikma Pharmaceuticals. Furthermore, Dr. Ameen Al Fraih, Logistics General Director of National Unified Procurement Company (NUPCO) will present a case study on the topic ‘NUPCO side of future supply chain transformation in the Kingdom’. Whereas, Mr. Youssef Musmar, Chief Supply Chain Officer, Tamer Group will be talking on the topic “Pharmaceutical Traceability”

A specialised post Congress course on Day 3 will be delivered by Saddam Ul Huq, Global QA Senior Manager, Distribution & Cold Chain, GSK, United Kingdom. Mr Saddam is an expert in Cold Chain Technologies, Logistics and Distribution of Vaccines and GDP related topics. The course will focus on important topics of Good Distribution Practices for Temperature Sensitive Pharmaceuticals.

About Maarefah Management:

Maarefah Management is a world-class events, training and association management company that works closely with government institutions, industry bodies, and professional associations to help individual’s career development in order to grow and sustain successful businesses. Through four main divisions, Maarefah offers a comprehensive professional services ranging from events management, leadership development training, market research and association administration across a number of industries. The company’s conferences and specialized training courses are developed by well experienced technical committees who create up-to-date scientific and technical programs tackling current and critical industry issues. Visit: http://www.maarefah-management.com 

About the Saudi Pharmaceutical Society:

The Saudi pharmaceutical society (SPS) is a non-profit professional organization founded in 1988 with aim of contributing to the planning and development of the pharmacy profession. The Saudi society for pharmacy is a considerable panel that represents pharmacists around the Kingdom of Saudi Arabia, and it was established on 7/5/1408 AH in order to organise and put within a framework all pharmaceutical work and to directly contribute to the planning and development aiming at elevating the level of pharmacy professions.  The Honorary President is his Royal Highness Prince Fahad Bin Sultan bin Abdulaziz (The Governor of Tabuk Region). Visit: https://www.saudipharmsociety.com 

For more information:
Paula Popova
Business Development Manager
Maarefah Management DMCC
M: +971 58 895 7245 
E: paula.p@maarefah-management.org 
W: www.intl-ccm.com 

For Media Queries:
Nafeesa Mohammed
PR Manager
International Cold Chain Management Congress
Mail: nafeesampallikunhi@gmail.com 
Mob: +971508274288

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.